Catherine Turkel

Catherine Turkel, PharmD, PhD, MBA, is a highly experienced pharmaceutical executive with a diverse background in drug development, regulatory affairs, and strategic leadership. Currently serving as a Board Director for Lexaria Bioscience and the Prostate Cancer Research Foundation, as well as a member of the Translational Scientific Advisory Committee for Proven Connect, Catherine has previously held significant roles such as CEO and Founder of Nezee Therapeutics and President of Novus Therapeutics. With a robust track record at Allergan as Vice President and Global Project Team Leader for Neurology and Pain, and senior positions at Cypros Pharmaceutical and IVAC Corporation, Catherine has expertise in clinical strategy, R&D operations, and corporate governance. Catherine holds a PharmD from the University of the Pacific, a PhD in Organization and Management/Leadership from Capella University, and an MBA from the University of California, Irvine.